Cooling method for intensive care

QuickCool

QuickCool is a Swedish medtech company, founded in 2003 to provide Targeted Temperature Management (TTM) solutions following cardiac arrest, stroke, and high grade fever. Its lead product, the QuickCool System, enables rapid cooling via the nasal cavity, to cool the body via the brain. QuickCool operates a lean structure typical of a startup, with three employees. The company’s scientific advisory board is chaired by TTM researcher Hans Friberg. QuickCool is listed on Aktietorget and headquartered in Lund.

Financials

QUICKCOOL

SEKm 2017 2018 2019
Sales 0 0 3
Sales growth (%) 0 0 0
EBITDA -5 -9 -12
EBITDA margin (%) 0 0 -435,7
EBIT adj 9 9 5
EBIT adj margin (%) 0 0 186,4
Pretax profit -5 -16 -13
EPS rep -0,26 -0,81 -0,67
EPS growth (%) 46,1 -208,9 17,4
EPS adj 0,49 0,13 0,22
DPS 0 0 0
EV/EBITDA (x) -5,3 -2,9 -2,7
EV/EBIT adj (x) 2,6 2,8 6,3
P/E (x) -6,5 -1,1 -1,3
P/E adj (x) 3,4 7 4
EV/sales (x) 0 0 11,7
FCF yield (%) -60,5 -96,7 -77,7
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 1,4 -1 -1,2

Main shareholders

QuickCool

Main shareholders Share capital % Voting shares %
Parkallen Invest AB 23.5 % 23.5 %
Mats Danielsson 8.0 % 8.0 %
Avanza Pension 6.8 % 6.8 %
Tadeusz Wojciech Wieloch 3.5 % 3.5 %
Fredrik Lindblad 3.5 % 3.5 %
Nordnet Pensionsförsäkring 2.5 % 2.5 %
Rita Löfgren 2.5 % 2.5 %
Henrik Gustafsson 2.4 % 2.4 %
Fredrik Radencrantz 2.0 % 2.0 %
Askudden AB 1.6 % 1.6 %